Event Description

Central California Hematology Oncology Conference: Biomarker Guided Therapy to Improve Patient Outcomes 2023 Fresno United States

The Central California Hematology Oncology Conference: Biomarker Guided Therapy to Improve Patient Outcomes is a 1-day educational and scientific meeting that will focus on the updates in the biomarker-guided management of patients with common malignancies. This conference will feature experts discussing the latest diagnostic, therapeutic, and supportive care strategies in cancer management. In addition, expert faculty will place key abstract findings from the 2023 ASCO Annual Meeting into a clinical context and discuss how the results may change the current standards of care. The goals of this conference are to review and critically assess practice-changing results of practice-changing clinical data and expert recommendations to incorporate biomarker-guided therapy in the management of patients with cancer.

End Date
Start Date
Total CME Credits
6
For registration/tickets purchase:
https://education.binayfoundation.org/content/central-california-hematology-oncology-conference#group-tabs-node-course-default7
Currency Symbol:
$
Event Cost:
100
Session I: Women’s Cancer
Session II: General Oncology
Session III: Hematologic Malignancies
Session IV: General Oncology
Session V: Tumor Board Style Case-Based Discussions
Event Types (Select all that apply)
Medical Conference
Event Sponsors
Novocure, Inc.
Event Registration Contact Email
support@binayfoundation.org
Event Information Contact Email
amanda.c@binayfoundation.org
CME Credit Fall Under
1-10
CME Credits
Yes
Exhibits
Central California Hematology Oncology Conference: Biomarker Guided Therapy to Improve Patient Outcomes 2023 Fresno United States
Abstract Submission Deadline
Abstract guidelines

Central California Hematology Oncology Conference: Biomarker Guided Therapy to Improve Patient Outcomes 2023 Fresno United States

(+1) 206-575-7771
Medical Events Worldwide
12922 SE 299th Street, Auburn WA 98092 USA